Compare RYTM & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RYTM | CWST |
|---|---|---|
| Founded | 2008 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.4B |
| IPO Year | 2017 | 1997 |
| Metric | RYTM | CWST |
|---|---|---|
| Price | $97.07 | $90.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $131.14 | $115.71 |
| AVG Volume (30 Days) | ★ 421.1K | 375.9K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,836,841,000.00 |
| Revenue This Year | $55.34 | $10.95 |
| Revenue Next Year | $86.06 | $6.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.95 |
| 52 Week Low | $74.50 | $74.05 |
| 52 Week High | $122.20 | $107.96 |
| Indicator | RYTM | CWST |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 46.51 |
| Support Level | $99.14 | $88.45 |
| Resistance Level | $113.04 | $94.72 |
| Average True Range (ATR) | 3.98 | 2.40 |
| MACD | -0.78 | -0.37 |
| Stochastic Oscillator | 19.75 | 33.02 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.